AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Syneos HealthExelixisPRA Health SciencesBTGMedpace
SymbolNASDAQ:SYNHNASDAQ:EXELNASDAQ:PRAHOTCMKTS:BTGGFNASDAQ:MEDP
Price Information
Current Price$62.08$23.17$109.50$10.05$90.41
52 Week RangeBuyBuyHoldN/AHold
Beat the Market™ Rank
Overall Score1.31.91.40.51.5
Analysis Score2.33.42.20.02.1
Community Score2.82.62.62.42.4
Dividend Score0.00.00.00.00.0
Ownership Score0.01.01.00.01.0
Earnings & Valuation Score1.32.51.30.01.9
Analyst Ratings
Consensus RecommendationBuyBuyHoldN/AHold
Consensus Price Target$60.45$28.92$101.00N/A$86.50
% Upside from Price Target-2.62% downside24.80% upside-7.76% downsideN/A-4.32% downside
Trade Information
Market Cap$6.38 billion$7.44 billion$6.89 billion$3.88 billion$3.17 billion
Beta1.791.51.090.261.22
Average Volume672,7563,855,085497,075777314,508
Sales & Book Value
Annual Revenue$4.68 billion$967.78 million$3.07 billionN/A$860.97 million
Price / Sales1.387.342.28N/A3.71
Cashflow$5.27 per share$1.04 per share$7.37 per shareN/A$3.83 per share
Price / Cash11.7822.2614.86N/A23.63
Book Value$29.19 per share$5.55 per share$17.23 per shareN/A$20.16 per share
Price / Book2.134.176.36N/A4.48
Profitability
Net Income$131.26 million$321.01 million$243.02 millionN/A$100.44 million
EPS$2.83$1.02$4.80N/A$3.02
Trailing P/E Ratio33.5624.9129.920.0031.18
Forward P/E Ratio18.9829.3322.1725.68
P/E GrowthN/A$1.47N/AN/AN/A
Net Margins4.13%30.01%7.66%N/A12.37%
Return on Equity (ROE)10.33%18.01%27.59%N/A16.96%
Return on Assets (ROA)4.05%16.17%8.39%N/A10.84%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.03%N/A1.30%N/A0.07%
Current Ratio1.23%8.09%0.93%N/A0.89%
Quick Ratio1.23%7.98%0.93%N/A0.89%
Ownership Information
Institutional Ownership PercentageN/A79.99%98.27%N/A79.80%
Insider Ownership Percentage0.44%4.50%1.30%N/A26.00%
Miscellaneous
Employees24,00048417,5001,6313,500
Shares Outstanding104.17 million306.66 million63.72 million386.49 million35.37 million
Next Earnings Date8/4/2020 (Estimated)7/29/2020 (Estimated)7/29/2020 (Estimated)N/A7/27/2020 (Confirmed)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.